BackNabriva Therapeutics Plc Overview
Nabriva Therapeutics Plc

Nabriva Therapeutics Plc Target Price

Analysts' 12-month price predictions for NBRV.

Get informed when a big investor buys or sells

+ Follow

Share Price

$1.42

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2023-01-06Northland SecuritiesCarl Byrnes$129.6% downsideOpen